OCUL(Ocular Therapeutix, Inc.) · 财务报表

OCUL(Ocular Therapeutix, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$43.52M$51.49M$58.44M$63.72M$51.95M
毛利润$39.12M$46.95M$53.16M$58.10M$45.38M
营业利润−$78.04M−$78.65M−$82.38M−$171.78M−$270.02M
净利润−$6.55M−$71.04M−$80.74M−$193.51M−$265.94M
经营现金流−$65.55M−$59.60M−$70.23M−$134.68M−$204.88M
自由现金流−$66.74M−$63.32M−$76.32M−$135.97M−$216.89M
摊薄每股收益—$-0.97$-1.02$-1.22$-1.42

Ocular Therapeutix, Inc. OCUL